Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.34
Bid: 40.78
Ask: 41.52
Change: 0.96 (2.38%)
Spread: 0.74 (1.815%)
Open: 39.92
High: 41.82
Low: 39.92
Prev. Close: 40.38
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Jul 2023 16:36

RNS Number : 8413F
Assura PLC
12 July 2023
 

12 July 2023

Assura plc

("the Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that on 6 July 2023 the following named PDMRs were granted the following share awards over Ordinary Shares of 10 pence each in the Company under the Company's Performance Share Plan ("PSP").

PDMR

Position

Number of Share Awards Granted

Jonathan Murphy

CEO

1,630,779

Jayne Cottam

CFO

999,242

 

These awards are subject to three performance conditions which will be determined after the 2025/26 financial year. 33% of the award shares are subject to an absolute Total Shareholder Return ("TSR") performance condition, 33% of the award shares are subject to a total accounting return growth ("TAR") performance condition and the remaining 33% are subject to ESG measures. Details of the performance conditions are set out in the Company's Directors' Remuneration Report for 2022/23.

In addition, the following PDMRs were granted restricted shares awards over Ordinary Shares of 10 pence each in the Company under the PSP.

PDMR

Position

Number of Restricted Share Awards Granted

Orla Ball

General Counsel

75,823

Robert James

Interim CIO

75,823

Sarah Taylor

Chief People Officer

75,823

 

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Grant of options under the PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

 

1,630,779

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

1,630,779

 

£NIL GBP

e)

Date of the transaction

 

6 July 2023

f)

Place of the transaction

 

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jayne Cottam

2

Reason for the notification

 

a)

Position/status

 

CFO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Grant of options under the PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

 

999,242

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

999,242

 

£NIL GBP

e)

Date of the transaction

 

6 July 2023

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Orla Ball

2

Reason for the notification

 

a)

Position/status

 

General Counsel

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Grant of restricted share awards under the PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

 

75,823

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

75,823

 

£NIL GBP

e)

Date of the transaction

 

6 July 2023

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Robert James

2

Reason for the notification

 

a)

Position/status

 

Interim CIO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Grant of restricted share awards under the PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

 

75,823

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

75,823

 

£NIL GBP

e)

Date of the transaction

 

6 July 2023

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Sarah Taylor

2

Reason for the notification

 

a)

Position/status

 

Chief People Officer

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Grant of restricted share awards under the PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

 

75,823

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

75,823

 

£NIL GBP

e)

Date of the transaction

 

6 July 2023

f)

Place of the transaction

 

XLON

 

- ENDS -

For more information, please contact:

 

Assura plc

 

Tel: 0161 515 2043

Orla Ball, General Counsel

David Purcell, Investor Relations Director

 

Email: Investor@assura.co.uk

FGS Global

Gordon SimpsonJames Thompson

Tel: 0207 251 3801

Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

 

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDRXXBDGXD
Date   Source Headline
14th Jan 201512:42 pmRNSResults of Shareholder Meetings
12th Jan 20157:00 amRNSForward funding and acquisition update
7th Jan 20157:00 amRNSAssura completes Sudbury Community Health Centre
17th Dec 20145:27 pmRNSPosting of Shareholder Circular & Meeting Notices
17th Dec 201410:16 amRNSAcquisition of a medical centre for £10.1 million
16th Dec 201412:12 pmRNSNew Corporate Structure
15th Dec 20143:12 pmRNSAcquisition of three medical centres for £11.5m
3rd Dec 20147:00 amRNSAssura completes Kidderminster purchase agreement
2nd Dec 20143:22 pmRNSNotification of Major Interest In Shares
28th Nov 20144:40 pmRNSSecond Price Monitoring Extn
28th Nov 20144:35 pmRNSPrice Monitoring Extension
28th Nov 201410:05 amRNSTotal Voting Rights
27th Nov 20142:26 pmRNSConfirmation of Quarterly Interim Dividend
25th Nov 20147:00 amRNSInterim Results 2014
6th Nov 20147:00 amRNS£63m acquisition and £21m development agreement
3rd Nov 20143:47 pmRNSNotification of Major Interest in Shares
3rd Nov 201412:20 pmRNSNotification of Major Interest in Shares
3rd Nov 20147:00 amRNSAssura adds four new medical centres
22nd Oct 20145:42 pmRNSNotification of Major Interest in Shares
22nd Oct 20144:52 pmRNSNotification of Major Interest in Shares
22nd Oct 201410:23 amRNSNotification of Major Interest in Shares
20th Oct 20141:00 pmRNSNotification of Major Interest in Shares
17th Oct 20149:25 amRNSNotification of Major Interest in Shares
16th Oct 20145:37 pmRNSNotification of Major Interest in Shares
16th Oct 20145:32 pmRNSNotification of Major Interest in Shares
16th Oct 20141:29 pmRNSDirector/PDMR Shareholding
16th Oct 20141:29 pmRNSTR-1: Notification of Major Interest in Shares
16th Oct 201412:38 pmRNSNotification of Major Interest in Shares
15th Oct 20142:58 pmRNSConfirmation of Quarterly Interim Dividend
14th Oct 20143:36 pmRNSResult of Extraordinary General Meeting
14th Oct 20143:15 pmRNSNotification of Major Interest in Shares
13th Oct 20144:27 pmRNSTR-1: Notification of Major Interest in Shares
13th Oct 20142:54 pmRNSTR-1: Notification of Major Interest in Shares
10th Oct 20147:00 amRNSResult of Proposed Share Issue
30th Sep 20146:05 pmRNSTR-1: Notification of Major Interest In Shares
24th Sep 20141:56 pmRNSPublication of Prospectus
24th Sep 20147:00 amRNSProposed Share Issue and Notice of EGM
4th Sep 201411:46 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
21st Aug 20147:00 amRNSAcquisition and funding agreement
14th Aug 201411:14 amRNSNotification of Major Interest in Shares
13th Aug 20145:08 pmRNSNotification of Major Interest in Shares
31st Jul 20147:00 amRNSInterim Management Statement
23rd Jul 20147:00 amRNSAcquisition of Medical Centre
22nd Jul 20145:29 pmRNSAnnual Information Update
22nd Jul 20144:57 pmRNSResult of AGM
1st Jul 201412:16 pmRNSTotal Voting Rights and Issued Share Capital
1st Jul 20149:24 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
23rd Jun 20145:15 pmRNSNotification of Major Interest in Shares
20th Jun 20143:34 pmRNSAnnual Report & Notice of AGM
13th Jun 20147:00 amRNSAcquisition of 28 medical centres for £107 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.